pharma · Lupus Nephritis · Generalized Myasthenia Gravis · AUPH
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1196 Hwy 3 South, Northfield, MN 55057, US
- Founded
- 2007
- Employees
- 81
- Programs
- 14
- Drugs
- 10
- Patents
- 7
Aurinia Pharmaceuticals projects
5 ClinicalTrials.gov programs sponsored by Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
0.05% Voclosporin Ophthalmic Solution (VOS)
Aurinia Pharmaceuticals
Dry Eye Syndrome
1 trial -
Voclosporin
Aurinia Pharmaceuticals
Adolescent Lupus Nephritis
2 trials -
Voclosporin
Aurinia Pharmaceuticals
Lupus Nephritis
3 trials -
voclosporin
Aurinia Pharmaceuticals
Psoriasis
3 trials -
voclosporin
Aurinia Pharmaceuticals
Renal Transplantation
1 trial
Frequently asked questions
How many clinical projects does Aurinia Pharmaceuticals have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.